CD274 and neoplasm: In recent years, substantial advancements have been made in the field of tumor immunotherapy, notably the triumphant integration of the B7 family molecule PD-L1 and its receptor PD-1 inhibitors into clinical practice, heralding new perspectives for cancer treatment.